Health Services

Dáil Éireann Debate, Tuesday - 27 January 2026

• Díospóireachtaí
• Aimsigh díospóireacht
  • Díospóireachtaí na Dála
  • Díospóireachtaí an tSeanaid
  • Díospóireachtaí Coiste
• Aimsigh vótáil
  • Vótálacha na Dála
  • Vótálacha an tSeanaid
  • Vótálacha Coiste
• Ceisteanna Parlaiminte
  • Ceisteanna scríofa
  • Ceisteanna ó bhéal
• Leideanna cuardaigh
• Nuair a bhíonn tionchar tromchúiseach ag aithrisí

Tuesday, 27 January 2026

Ceisteanna (1078)

David Cullinane

Ceist:

1078. Deputy David Cullinane asked the Minister for Health if she has given consideration to providing drug payment scheme cover for GLP-1 receptor agonists and similar for metabolic management for PCOS and similar endocrine conditions; and if she will make a statement on the matter. [6250/26]

Freagraí scríofa

Minister for Health

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

• An Freagra Roimhe Sin
• An Chéad Fhreagra eile